This article was originally published in Start Up
TeraMed and its competitors are developing endovascular grafting systems for the repair of aortic aneurysms that could do for vascular surgery what angioplasty did for cardiovascular surgery.
You may also be interested in...
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.